Antibodies against recombinant alpha-galactosidase A in Fabry disease: Subclass analysis and impact on response to treatment von van der Veen, S.J., van Kuilenburg, A.B.P., Hollak, C.E.M., Kaijen, P.H.P., Voorberg, J., Langeveld, M.

Volltext

Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature von Voorink-Moret, M., Goorden, S.M.I., van Kuilenburg, A.B.P., Wijburg, F.A., Ghauharali-van der Vlugt, J.M.M., Beers-Stet, F.S., Zoetekouw, A., Kulik, W., Hollak, C.E.M., Vaz, F.M.

Volltext

Mitochondrial neurogastrointestinal encephalomyopathy: Clinical and biochemical impact of allogeneic stem cell transplantation in a Greek patient with one novel TYMP mutation von Paisiou, A., Rogalidou, M., Pons, R., Ioannidou, E., Dimakou, K., Papadopoulou, A., Vaz, F.M., Vessalas, G., Goorden, S.M.I., Roelofsen, J., Zoetekouw, A., Nieman, M.M., Dimitriou, E., Moraitou, M., Peristeri, I., Michelakakis, H., van Kuilenburg, A.B.P.

Volltext

Early start of enzyme replacement therapy in pediatric male patients with classical Fabry disease is associated with attenuated disease progression von van der Veen, S.J., Körver, S., Hirsch, A., Hollak, C.E.M., Wijburg, F.A., Brands, M.M., Tøndel, C., van Kuilenburg, A.B.P., Langeveld, M.

Volltext

Evaluation of predictive tests for screening for dihydropyrimidine dehydrogenase deficiency von van Staveren, M C, Jan Guchelaar, H, van Kuilenburg, A B P, Gelderblom, H, Maring, J G

Volltext

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity von Van Kuilenburg, A.B.P., Vreken, P., Beex, L.V.A.M., Meinsma, R., Van Lenthe, H., De Abreu, R.A., Van Gennip, A.H.

Volltext

Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients von Verly, I.R.N., Leen, R., Meinsma, J.R., Hooijer, G.K.J., Savci-Heijink, C.D., van Nes, J., Broekmans, M., Wanders, R.J.A., van Kuilenburg, A.B.P., Tytgat, G.A.M.

Volltext

Prevention of fluoropyrimidine toxicity: do we still have to try our patient's luck? von Danesi, R., Del Re, M., Ciccolini, J., Schellens, J.H.M., Schwab, M., van Schaik, R.H.N., van Kuilenburg, A.B.P.

Volltext

3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients von Verly, I.R.N., van Kuilenburg, A.B.P., Abeling, N.G.G.M., Goorden, S.M.I., Fiocco, M., Vaz, F.M., van Noesel, M.M., Zwaan, C.M., Kaspers, G.J.L., Merks, J.H.M., Caron, H.N., Tytgat, G.A.M.

Volltext

DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A von Henricks, L M, Lunenburg, C A T C, de Man, F M, Meulendijks, D, Frederix, G W J, Kienhuis, E, Creemers, G-J M, Baars, A, Dezentjé, V O, Rosing, H, Beijnen, J H, van Werkhoven, E, van Kuilenburg, A B P, van Schaik, R H N, Mathijssen, R H J, Swen, J J, Gelderblom, H, Cats, A, Guchelaar, H-J, Schellens, J H M

Volltext

Frequent intragenic rearrangements of DPYD in colorectal tumours von van Kuilenburg, A B P, Etienne-Grimaldi, M-C, Mahamat, A, Meijer, J, Laurent-Puig, P, Olschwang, S, Gaub, M-P, Hennekam, R C M, Benchimol, D, Houry, S, Letoublon, C, Gilly, F-N, Pezet, D, Andre, T, Faucheron, J-L, Abderrahim-Ferkoune, A, Vijzelaar, R, Pradere, B, Milano, G

Volltext

Evaluation of predictive tests for screening for dihydropyrimidine dehydrogenase deficiency von van Staveren, M.C, Guchelaar, H. Jan, van Kuilenburg, A.B.P, Gelderblom, H, Maring, J.G

Volltext

β-Ureidopropionase deficiency presenting with congenital anomalies of the urogenital and colorectal systems von Yaplito-Lee, J., Pitt, J., Meijer, J., Zoetekouw, L., Meinsma, R., van Kuilenburg, A.B.P.

Volltext

Lethal 5-fluorouracil toxicity associated with a novel mutation in the dihydropyrimidine dehydrogenase gene von van Kuilenburg, A. B. P., Baars, J. W., Meinsma, R., van Gennip, A. H.

Volltext

Inborn errors of pyrimidine degradation: Clinical, biochemical and molecular aspects von Gennip, A.H., Abeling, N.G.G.M., Vreken, P., Kuilenburg, A.B.P.

Volltext

Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer von Volk, J., Reinke, F., van Kuilenburg, A. B. P., van Gennip, A. H., Schlichting, C., Ganser, A., Schöffski, P.

Volltext

Urinary 3-Methoxytyramine is a biomarker for MYC activity in patients with neuroblastoma von Verly, I.R.N., Matser, Y.A.H., Leen, R., Meinsma, R., Fiocco, M., Koster, J., Volckmann, R., Savci-Heijjink, D., Cangemi, G., Barco, S., Valentijn, L.J., Tytgat, G.A.M., Kuilenburg, A.B.P. van

Volltext bestellen

Biochemical and imaging parameters in acid sphingomyelinase deficiency: potential utility as biomarkers von Eskes, E.C.B., Sjouke, B., Vaz, F.M., Goorden, S.M.I., Kuilenburg, A.B.P. van, Aerts, J.M.F.G., Hollak, C.E.M.

Volltext bestellen

Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy von Verschuur, A.C., Van Gennip, A.H., Leen, R., Muller, E.J., Elzinga, L., Voûte, P.A., Van Kuilenburg, A.B.P.

Volltext

Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea von Meinsma, R, Fernandez-Salguero, P, Van Kuilenburg, A B, Van Gennip, A H, Gonzalez, F J

Volltext